Halozyme Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $8.1M | 9.4M | 0.86 |
| 2023-09-30 | $9.6M | 11M | 0.85 |
| 2023-06-30 | $13M | 16M | 0.83 |
| 2023-03-31 | $13M | 15M | 0.83 |
| 2022-12-31 | $11M | 12M | 0.97 |
| 2022-06-30 | $7.7M | 8.7M | 0.89 |
| 2022-03-31 | $7.7M | 8.7M | 0.88 |